Holen Sie sich die Stockscreener-App
42.60
1.31%
0.55
Handel nachbörslich:
42.60
Schlusskurs vom Vortag:
$42.05
Offen:
$41.66
24-Stunden-Volumen:
2.04M
Relative Volume:
2.72
Marktkapitalisierung:
$2.70B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-107.85M
KGV:
-12.68
EPS:
-3.36
Netto-Cashflow:
$-106.82M
1W Leistung:
-3.29%
1M Leistung:
-6.89%
6M Leistung:
+19.46%
1J Leistung:
+180.45%
1-Tages-Spanne:
$40.96
$45.06
1-Wochen-Bereich:
$40.73
$45.27
52-Wochen-Spanne:
$14.20
$51.61
Vera Therapeutics Inc Stock (VERA) Company Profile
Firmenname
Vera Therapeutics Inc
Sektor
Branche
Telefon
650-770-0077
Adresse
2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE
Vergleichen Sie VERA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VERA
Vera Therapeutics Inc
|
42.60 | 2.70B | 0 | -107.85M | -106.82M | -2.21 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Vera Therapeutics Inc Stock (VERA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-21 | Eingeleitet | Wells Fargo | Overweight |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-01-25 | Eingeleitet | Oppenheimer | Outperform |
| 2024-01-08 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-12-18 | Eingeleitet | Raymond James | Outperform |
| 2023-11-10 | Hochstufung | Jefferies | Hold → Buy |
| 2023-08-16 | Eingeleitet | Guggenheim | Buy |
| 2023-01-04 | Herabstufung | Jefferies | Buy → Hold |
| 2023-01-04 | Herabstufung | Wedbush | Outperform → Neutral |
| 2022-07-12 | Eingeleitet | JP Morgan | Overweight |
| 2022-05-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-04-19 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Vera Therapeutics Inc Aktie (VERA) Neueste Nachrichten
Vera Therapeutics, Inc. (NASDAQ:VERA) CEO Sells $753,725.00 in Stock - MarketBeat
Vera Therapeutics Insider Sold Shares Worth $753,680, According to a Recent SEC Filing - Marketscreener.com
Wellington Management Group LLP Sells 92,568 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA) - MarketBeat
Vera Therapeutics, Inc. (NASDAQ:VERA) Shares Sold by State Street Corp - MarketBeat
Lord Abbett & CO. LLC Increases Position in Vera Therapeutics, Inc. (NASDAQ:VERA) - MarketBeat
Vera Therapeutics, Inc. (NASDAQ:VERA) Shares Purchased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Certain Class A common stock of Vera Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 15-DEC-2024. - Marketscreener.com
Marshall Fordyce Sells 17,500 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA) Stock - MarketBeat
Vera Therapeutics CEO sells shares worth over $821k By Investing.com - Investing.com Canada
Vera Therapeutics CEO sells shares worth over $821k - Investing.com
Vera Therapeutics, Inc. (NASDAQ:VERA) Shares Purchased by Y Intercept Hong Kong Ltd - MarketBeat
VERAVera Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Vera Therapeutics Grants $8.5M in Stock Options, RSUs to Attract Key Talent - StockTitan
Pier Capital LLC Invests $4.57 Million in Vera Therapeutics, Inc. (NASDAQ:VERA) - MarketBeat
Vera Therapeutics, Inc. (NASDAQ:VERA) Shares Purchased by Point72 Asset Management L.P. - MarketBeat
Vera Therapeutics, Inc. (NASDAQ:VERA) Shares Bought by Charles Schwab Investment Management Inc. - MarketBeat
Verition Fund Management LLC Invests $1.91 Million in Vera Therapeutics, Inc. (NASDAQ:VERA) - MarketBeat
Vera Therapeutics, Inc. (NASDAQ:VERA) Shares Sold by Readystate Asset Management LP - MarketBeat
Vera Therapeutics, Inc. (NASDAQ:VERA) Shares Sold by Fmr LLC - MarketBeat
Vera Therapeutics, Inc. (NASDAQ:VERA) Stock Holdings Lifted by HighVista Strategies LLC - MarketBeat
Cinctive Capital Management LP Has $2.14 Million Holdings in Vera Therapeutics, Inc. (NASDAQ:VERA) - MarketBeat
Intech Investment Management LLC Buys New Shares in Vera Therapeutics, Inc. (NASDAQ:VERA) - MarketBeat
Intech Investment Management LLC Purchases New Holdings in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
Analysts Set Vera Therapeutics, Inc. (NASDAQ:VERA) Target Price at $59.22 - MarketBeat
Objective long/short (VERA) Report - Stock Traders Daily
Vera Therapeutics Grants 161,000 Share Awards to New Chief Legal Officer | VERA Stock News - StockTitan
Wells Fargo Initiates Coverage of Vera Therapeutics (VERA) with Overweight Recommendation - MSN
Vera Therapeutics initiated with an Overweight at Wells Fargo - MSN
Vera Therapeutics (NASDAQ:VERA) Coverage Initiated at Wells Fargo & Company - MarketBeat
GSA Capital Partners LLP Has $535,000 Stock Holdings in Vera Therapeutics, Inc. (NASDAQ:VERA) - MarketBeat
Wall Street Analysts Think Vera Therapeutics (VERA) Could Surge 27.26%: Read This Before Placing a Bet - MSN
Calif. Biotech Firm Vera Taps Veteran Chief Legal Officer - Law360
First Turn Management LLC Increases Stock Holdings in Vera Therapeutics, Inc. (NASDAQ:VERA) - MarketBeat
Vera hires Jason Carter as chief legal officer - BioCentury
Vera Therapeutics Appoints Jason S. Carter as Chief Legal Officer - GlobeNewswire
Vera Therapeutics Appoints Former Kite Pharma Legal Head as Chief Legal Officer | VERA Stock News - StockTitan
Vera Therapeutics Appoints Jason S. Carter as Chief Legal Officer By Investing.com - Investing.com Canada
Vera Therapeutics Inc (VERA) Stock Price & Chart | Trade Now - Capital.com
(VERA) Proactive Strategies - Stock Traders Daily
COMMODORE CAPITAL LP Adjusts Stake in Vera Therapeutics Inc - GuruFocus.com
Kynam Capital Management, LP Increases Stake in Vera Therapeutics Inc - GuruFocus.com
500: Something went wrong - Investing.com India
Vera Therapeutics stock soars to all-time high of $50.98 - Investing.com
Vera Therapeutics stock soars to all-time high of $50.98 By Investing.com - Investing.com Australia
Vera Therapeutics (NASDAQ:VERA) Reaches New 1-Year HighHere's What Happened - MarketBeat
FMR LLC Reduces Stake in Vera Therapeutics Inc - GuruFocus.com
Vera Therapeutics Partners with University of Michigan on the NEPTUNE Match Project and PIONEER Study - The Manila Times
Vera Therapeutics (NASDAQ:VERA) Posts Quarterly Earnings Results, Misses Expectations By $0.21 EPS - MarketBeat
Vera Therapeutics to Participate at Upcoming Investor Conferences - The Manila Times
Finanzdaten der Vera Therapeutics Inc-Aktie (VERA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Vera Therapeutics Inc-Aktie (VERA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Fordyce Marshall | PRESIDENT AND CEO |
Dec 18 '24 |
Option Exercise |
2.90 |
17,500 |
50,694 |
90,965 |
| Fordyce Marshall | PRESIDENT AND CEO |
Dec 18 '24 |
Sale |
43.07 |
17,500 |
753,680 |
85,942 |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):